Your fact-checks will appear here
The FDA has approved several weight-loss medications, including GLP-1s and related multimodal peptides, which have shown significant weight loss in clinical trials.
Prescription GLP‑1 receptor agonists are clinically tested, regulated drugs that mimic the GLP‑1 hormone to slow gastric emptying, reduce appetite and produce substantial, trial-proven weight loss, wh...
GLP-1 receptor agonists are effective medicines that have transformed diabetes and obesity treatment, delivering substantial weight loss and cardiovascular and metabolic benefits in trials and real-wo...
Randomized clinical trials have shown GLP‑1 receptor agonists produce substantially greater average weight loss than lifestyle interventions alone in protocolized studies—examples include semaglutide ...
Peer‑reviewed clinical reviews and meta‑analyses show a mixed, mostly modest body of evidence that a handful of common over‑the‑counter ingredients—caffeine and green tea catechins (often together), s...
A raft of FDA‑approved prescription weight‑loss medications exists beyond the spotlighted GLP‑1 class — older drugs like phentermine and orlistat remain approved even as GLP‑1s and related multimodal ...